Advertisement

International Urology and Nephrology

, Volume 46, Issue 10, pp 2045–2051 | Cite as

Protective effects of adiponectin on uncoupling of glomerular VEGF–NO axis in early streptozotocin-induced type 2 diabetic rats

  • Ningning Hou
  • Na Huang
  • Fang Han
  • Jiangang Zhao
  • Xue Liu
  • Xiaodong SunEmail author
Nephrology - Original Paper

Abstract

Purpose

To determine whether adiponectin could reduce microalbuminuria and provide renal protective effects by improving endothelial dysfunction and uncoupling of the glomerular vascular endothelial growth factor (VEGF)–nitric oxide (NO) axis in streptozotocin-induced type 2 diabetic rats.

Methods

Wistar rats were randomly divided into normal control group, diabetic nephropathy (DN) group induced by high-fat feeding and streptozotocin, diabetic rats injected with adenovirus-expressed adiponectin (AD-AdipoQ), and diabetic rats injected with AD-IRES-EGFP as control. Blood and urine samples were collected. Endothelium-dependent vasodilatation (EDV) of the aorta was measured. Renal tissues were collected for CD34 immunohistochemistry. Glomerular NO and VEGF levels were measured by the Griess reaction and Western blot testing, respectively.

Results

Injections of AD-AdipoQ significantly increased serum adiponectin levels and reduced the urinary albumin-to-creatinine ratio in diabetic rats (P < 0.05). The levels of plasma glucose, serum insulin, high-sensitivity C-reactive protein, and malondialdehyde were significantly reduced in diabetic rats after injections of AD-AdipoQ (P < 0.05). Severe EDV impairment was observed in the DN group, which was improved by AD-AdipoQ. CD34 expression in the glomeruli was also higher in diabetic rats, indicating increased proliferation of glomerular endothelial cells. However, AD-AdipoQ improved the increased proliferation of endothelial cells in the glomeruli. Diabetic rats showed increased glomerular VEGF levels and reduced NO levels. This uncoupling of the VEGF–NO axis was partially improved by AD-AdipoQ.

Conclusion

Adiponectin reduces the degree of microalbuminuria and has renal protective effects by improving endothelial dysfunction and uncoupling of the glomerular VEGF–NO axis in early diabetic nephropathy.

Keywords

Adiponectin Microalbuminuria Vascular endothelial growth factor Nitric oxide Diabetic nephropathy 

Notes

Acknowledgments

This work was supported by the National Natural Science Foundation of China (Grants NO. 81300688), Weifang Health Bureau Program (2013021), the Science and Technology Innovation Fund of Affiliated Hospital of Weifang Medical University (NO. K12CX1007), and the Science and Technology Innovation Fund of Weifang Medical University (NO. K1302017).

Conflict of interest

The authors declare that they have no conflict of interest.

References

  1. 1.
    Salvatore SP, Reddi AS, Chandran CB, Chevalier JM, Okechukwu CN, Seshan SV (2014) Collapsing glomerulopathy superimposed on diabetic nephropathy: insights into etiology of an under-recognized, severe pattern of glomerular injury. Nephrol Dial Transplant 29(2):392–399PubMedCrossRefGoogle Scholar
  2. 2.
    Hillege HL, Fidler V, Diercks GF, van Gilst WH, de Zeeuw D, van Veldhuisen DJ et al (2002) Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation 106(14):1777–1782PubMedCrossRefGoogle Scholar
  3. 3.
    Klausen KP, Parving HH, Scharling H, Jensen JS (2009) Microalbuminuria and obesity: impact on cardiovascular disease and mortality. Clin Endocrinol (Oxf) 71(1):40–45CrossRefGoogle Scholar
  4. 4.
    Nakagawa T, Sato W, Kosugi T, Johnson RJ (2013) Uncoupling of VEGF with endothelial NO as a potential mechanism for abnormal angiogenesis in the diabetic nephropathy. J Diabetes Res 2013:184539PubMedCrossRefPubMedCentralGoogle Scholar
  5. 5.
    Sun X, Yu Y, Han L (2013) High FFA levels related to microalbuminuria and uncoupling of VEGF-NO axis in obese rats. Int Urol Nephrol 45(4):1197–1207PubMedCrossRefGoogle Scholar
  6. 6.
    Tian S, Gan Y, Li J, Wang L, Shen J, Liu T et al (2011) Imbalance of glomerular VEGF-NO axis in diabetic rats: prevention by chronic therapy with propyl gallate. J Nephrol 24(4):499–506PubMedCrossRefGoogle Scholar
  7. 7.
    Nakamaki S, Satoh H, Kudoh A, Hayashi Y, Hirai H, Watanabe T (2011) Adiponectin reduces proteinuria in streptozotocin-induced diabetic Wistar rats. Exp Biol Med (Maywood) 236(5):614–620CrossRefGoogle Scholar
  8. 8.
    Wang B, Yu Y, Han L (2012) Adiponectin improves endothelial dysfunction caused by elevated FFAs levels, partially through cAMP-dependent pathway. Diabetes Res Clin Pract 97(1):119–124PubMedCrossRefGoogle Scholar
  9. 9.
    Hou N, Han F, Wang M, Huang N, Zhao J, Liu X et al (2014) Perirenal fat associated with microalbuminuria in obese rats. Int Urol Nephrol 46(4):839–845PubMedCrossRefGoogle Scholar
  10. 10.
    Sun X, Han F, Yi J, Hou N, Cao Z (2013) The effect of telomerase activity on vascular smooth muscle cell proliferation in type 2 diabetes in vivo and in vitro. Mol Med Rep 7(5):1636–1640PubMedGoogle Scholar
  11. 11.
    Sun X, Han F, Yi J, Han L, Wang B (2011) Effect of aspirin on the expression of hepatocyte NF-kappaB and serum TNF-alpha in streptozotocin-induced type 2 diabetic rats. J Korean Med Sci 26(6):765–770PubMedCrossRefPubMedCentralGoogle Scholar
  12. 12.
    Wang HJ, Jin YX, Shen W, Neng J, Wu T, Li YJ et al (2007) Low dose streptozotocin (STZ) combined with high energy intake can effectively induce type 2 diabetes through altering the related gene expression. Asia Pac J Clin Nutr 16(Suppl 1):412–417PubMedGoogle Scholar
  13. 13.
    Kono T, Saito M, Kinoshita Y, Satoh I, Shinbori C, Satoh K (2006) Real-time monitoring of nitric oxide and blood flow during ischemia-reperfusion in the rat testis. Mol Cell Biochem 286(1–2):139–145PubMedCrossRefGoogle Scholar
  14. 14.
    Spranger J (2003) Adiponectin and protection against type 2 diabetes mellitus. Lancet 361(9353):226228CrossRefGoogle Scholar
  15. 15.
    von Eynatten M, Liu D, Hock C, Oikonomou D, Baumann M, Allolio B et al (2009) Urinary adiponectin excretion: a novel marker for vascular damage in type 2 diabetes. Diabetes 58(9):2093–2099CrossRefGoogle Scholar
  16. 16.
    Stehouwer CD, Gall MA, Twisk JW, Knudsen E, Emeis JJ, Parving HH (2002) Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: progressive, interrelated, and independently associated with risk of death. Diabetes 51(4):1157–1165PubMedCrossRefGoogle Scholar
  17. 17.
    Stehouwer CD (2004) Endothelial dysfunction in diabetic nephropathy: state of the art and potential significance for non-diabetic renal disease. Nephrol Dial Transplant 19(4):778–781PubMedCrossRefGoogle Scholar
  18. 18.
    Nakagawa T (2007) Uncoupling of the VEGF-endothelial nitric oxide axis in diabetic nephropathy: an explanation for the paradoxical effects of VEGF in renal disease. Am J Physiol Renal Physiol 292(6):F1665–F1672PubMedCrossRefGoogle Scholar
  19. 19.
    Feliers D, Chen X, Akis N, Choudhury GG, Madaio M, Kasinath BS (2005) VEGF regulation of endothelial nitric oxide synthase in glomerular endothelial cells. Kidney Int 68(4):1648–1659PubMedCrossRefGoogle Scholar
  20. 20.
    Nakagawa T, Sato W, Sautin YY, Glushakova O, Croker B, Atkinson MA et al (2006) Uncoupling of vascular endothelial growth factor with nitric oxide as a mechanism for diabetic vasculopathy. J Am Soc Nephrol 17(3):736–745PubMedCrossRefGoogle Scholar
  21. 21.
    Hattori Y, Nakano Y, Hattori S, Tomizawa A, Inukai K, Kasai K (2008) High molecular weight adiponectin activates AMPK and suppresses cytokine-induced NF-kappaB activation in vascular endothelial cells. FEBS Lett 582(12):1719–1724PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2014

Authors and Affiliations

  • Ningning Hou
    • 1
  • Na Huang
    • 1
  • Fang Han
    • 2
  • Jiangang Zhao
    • 1
  • Xue Liu
    • 1
  • Xiaodong Sun
    • 1
    Email author
  1. 1.Department of EndocrinologyAffiliated Hospital of Weifang Medical UniversityWeifangChina
  2. 2.Department of PathologyAffiliated Hospital of Weifang Medical UniversityWeifangChina

Personalised recommendations